Skip to main content

Table 1 Demographic and clinical characteristics of study population (n = 62)

From: Germline and somatic mutations of multi-gene panel in Chinese patients with epithelial ovarian cancer: a prospective cohort study

Clinical characteristics N/n of Patients (%)
Age at diagnosis
  < 40 2/62(3.2%)
 40~50 18/62 (29.0%)
 50~60 20/62 (32.3%)
 60~70 18/62 (29.0%)
  ≥ 70 4/62 (6.5%)
FIGO stage
 I 6/62(9.7%)
 II 5/62 (8.1%)
 III 36/62 (58.1%)
 IV 9/62 (14.5%)
 NAa 6/62 (9.7%)
Primary or Recurrent
 Primary 48/62 (77.4%)
 Recurrent 14/62 (22.6%)
Tumor histopathology
 High-gradeb serous 48/62 (77.4%)
 Clear cell 5/62 (8.1%)
 Endometrioid 3/62 (4.8%)
 Low-gradec serous 1/62 (1.6%)
 Mucinous 1/62 (1.6%)
 Othersd 4/62 (6.5%)
Self, in addition to ovarian cancer
 Breast cancer 5/62(8.1%)
 No breast cancer 18/62 (91.9%)
Family history
 Breast cancer 3/62(4.8%)
 Ovarian cancer 7/62 (11.3%)
 Pancreatic cancer 1/62(1.6%)
 Pancreatic cancer 1/62(1.6%)
 Colon cancer 2/62(3.2%)
 Other cancer 18/62(29.0%)
 Breast or ovarian cancer 10/62(16.1%)
  1. a: NA = Not Available
  2. b: Grades 2–3
  3. c: Grade 1
  4. d: Other = one malignant Brenner, one squamous cell carcinoma, one mixed carcinomas, and one unclassified adenocarcinoma